Biomarkers of CIDP in patients with diabetes or CMT1

J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:14-7. doi: 10.1111/j.1529-8027.2011.00299.x.


Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease that targets the myelin sheaths in peripheral nerves. Primary demyelination can be detected by electrodiagnostic studies or nerve biopsy, but these do not distinguish between demyelination resulting from CIDP or from non-inflammatory causes such as diabetes or Charcot-Marie-Tooth type I. Consequently, the diagnosis of CIDP in such patients is often missed. Studies are needed to establish electrodiagnostic criteria for CIDP in patients with diabetes, and to identify biomarkers that distinguish between inflammatory and non-inflammatory causes of demyelinating neuropathy.

MeSH terms

  • Biomarkers / analysis*
  • Charcot-Marie-Tooth Disease / complications
  • Charcot-Marie-Tooth Disease / diagnosis*
  • Diabetic Neuropathies / complications
  • Diabetic Neuropathies / diagnosis*
  • Diagnosis, Differential
  • Humans
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / complications
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / diagnosis*


  • Biomarkers